ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
AstraZeneca PLC

AstraZeneca PLC (AZN)

73.58
-0.87
(-1.17%)
Closed February 16 4:00PM
73.58
0.01
(0.01%)
After Hours: 7:48PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 96.48B96.69B96.54B96.09B101.12B102.29B104.34B104.92B
Total Current Assets 22.59B22.27B22.84B22.5B25.05B25.59B25.39B24.16B
Cash and Equivalents 6.17B6.23B5.66B4.87B5.84B7.84B6.92B4.8B
Total Non-Current Assets 81.46B82.11B81.43B72.61B84.37B84.91B87.37B79.39B
Total Liabilities 59.43B60.88B59.13B58.87B61.95B64.79B64.74B64.12B
Total Current Liabilities 26.29B24.86B26.38B28.59B30.54B28.9B28.57B25.93B
Total Non-Current Liabilities 56.82B63.66B57.8B53.25B54.63B64.11B64.35B68.18B
Common Equity 387M387M387M387M388M388M388M388M
Retained Earnings -574M-1.83B-234M-434M1.5B-212M1.85B3.14B
Year End December 30 2024 20172018201920202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 63.35B60.65B61.38B66.73B105.36B96.48B101.12B104.04B
Total Current Assets 13.15B15.59B15.56B19.54B26.24B22.59B25.05B25.83B
Cash and Equivalents 3.32B4.83B5.37B7.83B6.33B6.17B5.84B5.49B
Total Non-Current Assets 16.64B14.04B14.6B15.64B39.29B37.06B39.17B40.87B
Total Liabilities 46.71B46.61B46.78B51.09B66.08B59.43B61.95B63.16B
Total Current Liabilities 16.38B16.29B18.12B20.31B22.59B26.29B30.54B27.87B
Total Non-Current Liabilities 45.89B47.67B44.88B48.78B72.37B56.82B54.63B62.92B
Total Equity 16.64B14.04B14.6B15.64B39.29B37.06B39.17B40.87B
Common Equity 317M317M328M328M387M387M388M388M
Retained Earnings 8.22B5.68B2.81B5.3B1.71B-574M1.5B3.16B